Chief Development Officer (CDO) @ (February 2019 - January 2023)
VP Cytokine Biology, Dist. Med. Fellow (ARMO) @ Eli Lilly and Company (October 2018 - February 2019)
Senior VP Preclinical and Clinial R and D @ (October 2017 - July 2018)
VP Preclinical and Clinical Research @ (January 2013 - October 2017)
CEO @ Targenics Inc (January 2011 - January 2013)
Fellow @ (January 2009 - December 2010)
Research Fellow @ (January 2008 - January 2009)
Senior Principal Scientist @ Schering -Plough Biopharma (January 2005 - January 2008)
Staff Scientist @ (January 2001 - January 2005)
Researcher @ (January 1999 - January 2001)
Ass. Scientist @ (January 1997 - January 1999)
Postdoctoral fellow @ Institute for Molecular Pathology (January 1994 - January 1997)
Martin Oft Education
FAU Erlangen-Nürnberg
MD (Medicine)
1986-1993
Martin Oft Skills
Biotechnology
Cell Biology
Cell Culture
Clinical Development
Immunology
Life Sciences
Molecular Biology
Operations
Clinical Operations
Research
Clinical Research
Marketing
Leadership
Management
Development
Business Development
Chemistry
Sales
Biochemistry
Customer Service
Martin Oft Summary
Martin Oft, based in San Francisco, CA, US, is currently a Chief Scientific Officer at Synthekine. Martin Oft brings experience from previous roles at Synthekine, Eli Lilly and Company and ARMO BioSciences. Martin Oft holds a 1986 - 1993 MD in Medicine @ FAU Erlangen-Nürnberg. With a robust skill set that includes Biotechnology, Cell Biology, Cell Culture, Clinical Development, Immunology and more. Martin Oft has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Martin Oft?
Find contact details for 700 million professionals.